Dignify Therapeutics

United States
Creve Coeur, Missouri, United States, 27709

Company profile

Dignify Therapeutics company profile

Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal cord injured, multiple sclerosis and similar patient populations. By combining novel pharmaceutical agents with drug delivery technology, Dignify Therapeutics will redefine the treatment of these disorders and restore the dignity of voluntary excretory function for these patients. The company was founded in 2013 and is headquartered in Raleigh, North Carolina.

Business identity

Contact email
[email protected]
Phone number
9199908561
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2013-01-01, Year

Headquarters

Postal code
27709
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
8
Total equity funding
$3M
Last funding
Grant / $1.2M / 2024-09-19
Last equity funding
Series Unknown / $3M
Investors
7
Lead investors
3
Founders
10
Articles
15

Founders and investors

Founders

Aura KullmannBenny WardDan RiccaEboo VersiEd BurgardKarl ThorLesley MarsonMary KatofiascTatyana TouzovaVelu Karicheti

Lead investors

Eshelman VenturesNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institutes of Health

Investors

Eshelman VenturesNational Institute on AgingNational Institutes of HealthNorth Carolina Biotechnology CenterRA Capital Management